Literature DB >> 25318989

Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

George R Thompson1, David A Stevens, Karl V Clemons, Josh Fierer, Royce H Johnson, Jane Sykes, George Rutherford, Michael Peterson, John W Taylor, Vishnu Chaturvedi.   

Abstract

Coccidioidomycosis ('Valley Fever'), caused by the inhalation of the fungus Coccidioides, remains a recalcitrant health problem in large parts of California. The incidence and severity of the disease continues to rise in many parts of the state. In this manuscript, we highlight unanswered questions about the disease. Specifically, the extent of disease burden, genetic determinants of host susceptibility, diagnostic and treatment guidelines, natural reservoirs of the pathogens, antifungal drug resistance, and fungal determinants of mild or severe disease are all areas awaiting in depth investigations. We also recommend establishment of a California Coccidioidomycosis Registry to improve clinical care and translational research.

Entities:  

Mesh:

Year:  2014        PMID: 25318989     DOI: 10.1007/s11046-014-9816-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  64 in total

1.  Pattern of 39,500 serologic tests in coccidioidomycosis.

Authors:  C E SMITH; M T SAITO; S A SIMONS
Journal:  J Am Med Assoc       Date:  1956-02-18

2.  Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis.

Authors:  Emily J Kirsch; Russell T Greene; Annalisa Prahl; Stanley I Rubin; Jane E Sykes; Michelle M Durkin; Lawrence J Wheat
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

3.  Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.

Authors:  Lisa F Shubitz; Jieh-Juen Yu; Chiung-Yu Hung; Theo N Kirkland; Tao Peng; Robert Perrill; Julie Simons; Jianmin Xue; Roger A Herr; Garry T Cole; John N Galgiani
Journal:  Vaccine       Date:  2006-04-18       Impact factor: 3.641

4.  A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.

Authors:  Eric J Tarcha; Venkatesha Basrur; Chiung-Yu Hung; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Coccidioidomycosis in workers at an archeologic site--Dinosaur National Monument, Utah, June-July 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-11-16       Impact factor: 17.586

6.  Occupational coccidioidomycosis in California: outbreak investigation, respirator recommendations, and surveillance findings.

Authors:  Rupali Das; Jennifer McNary; Kathleen Fitzsimmons; Dina Dobraca; Kate Cummings; Janet Mohle-Boetani; Charlotte Wheeler; Ann McDowell; Yulia Iossifova; Rachel Bailey; Kathleen Kreiss; Barbara Materna
Journal:  J Occup Environ Med       Date:  2012-05       Impact factor: 2.162

7.  Antigenemia detected in human coccidioidomycosis.

Authors:  M H Weiner
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

8.  Persistent pulmonary infection with an azole-resistant Coccidioides species.

Authors:  John D Kriesel; Deanna A Sutton; Susan Schulman; Annette W Fothergill; Michael G Rinaldi
Journal:  Med Mycol       Date:  2008-09       Impact factor: 4.076

9.  Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).

Authors:  Suzanne M Johnson; Nicholas W Lerche; Demosthenes Pappagianis; Joann L Yee; John N Galgiani; Richard F Hector
Journal:  Ann N Y Acad Sci       Date:  2007-03-08       Impact factor: 5.691

10.  Increase in reported coccidioidomycosis--United States, 1998-2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-29       Impact factor: 17.586

View more
  8 in total

1.  Evaluation of the Specificity of Two Enzyme Immunoassays for Coccidioidomycosis by Using Sera from a Region of Endemicity and a Region of Nonendemicity.

Authors:  Mark D Lindsley; YoonJi Ahn; Orion McCotter; Lalitha Gade; Steven F Hurst; Mary E Brandt; Benjamin J Park; Anastasia P Litvintseva
Journal:  Clin Vaccine Immunol       Date:  2015-08-05

2.  Large-Scale Land Development, Fugitive Dust, and Increased Coccidioidomycosis Incidence in the Antelope Valley of California, 1999-2014.

Authors:  Aaron J Colson; Larry Vredenburgh; Ramon E Guevara; Natalia P Rangel; Carl T Kloock; Antje Lauer
Journal:  Mycopathologia       Date:  2017-01-13       Impact factor: 2.574

3.  The Powers and Perils of PCR in the Search for the Natural Reservoirs of Coccidioides Species.

Authors:  Zhirong Li; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2017-06       Impact factor: 2.574

4.  Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.

Authors:  George R Thompson; Bridget M Barker; Nathan P Wiederhold
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

5.  Coccidioides immitis septic knee arthritis.

Authors:  Scott A Weisenberg
Journal:  BMJ Case Rep       Date:  2018-03-13

Review 6.  Mini-Review of Published Reports on Coccidioidomycosis in China.

Authors:  Xiao Li Wang; Si Wang; Chun Li An
Journal:  Mycopathologia       Date:  2015-09-09       Impact factor: 2.574

7.  Use of Population Genetics to Assess the Ecology, Evolution, and Population Structure of Coccidioides.

Authors:  Marcus M Teixeira; Bridget M Barker
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

Review 8.  Endemic Mycoses: What's New About Old Diseases?

Authors:  Ilan S Schwartz; Chris Kenyon; George R Thompson
Journal:  Curr Clin Microbiol Rep       Date:  2016-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.